Loading...
Accelerated Emavusertib Approval Will Redefine Oncology Care
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
-68.7%7D
-13.4%1Y
-68.7%7D
-13.4%You can edit this narrative until Aug 16 9:14 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 16 9:14 PM. Then, changes will post as Updates.